LENZ Therapeutics, Inc.
LENZ
$29.52
$0.642.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.65M | -10.22M | -10.25M | -16.65M | -23.69M |
| Total Depreciation and Amortization | 25.00K | 10.00K | 18.00K | 5.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 222.00K | 832.00K | 638.00K | 1.72M | -262.00K |
| Change in Net Operating Assets | 3.33M | -1.21M | -6.20M | -9.01M | 2.98M |
| Cash from Operations | -9.08M | -10.58M | -15.80M | -23.94M | -20.97M |
| Capital Expenditure | -149.00K | -186.00K | -133.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.71M | -62.04M | -98.26M | 18.00M | 15.17M |
| Cash from Investing | -11.86M | -62.23M | -98.39M | 18.00M | 15.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.00K | 29.83M | -- | 53.82M | 0.00 |
| Repurchase of Common Stock | -- | -- | -150.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -13.00K | -1.99M | 117.45M | -1.91M |
| Cash from Financing | 53.00K | 29.82M | -2.14M | 171.27M | -1.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.89M | -42.99M | -116.32M | 165.33M | -7.71M |